Accessibility Menu
Arrow-Thin-Down
S&P 500
6,941.47
-0.0%
-0.34
Arrow-Thin-Down
DJI
50,121.40
-0.1%
-66.74
Arrow-Thin-Down
NASDAQ
23,066.47
-0.2%
-36.01
Arrow-Thin-Down
Bitcoin
$67,770.00
+1.3%
+$895.13
Arrow-Thin-Down
SPOT
$487.19
+2.3%
+$11.17
Arrow-Thin-Down
SPGI
$390.76
-2.6%
-$10.32
Arrow-Thin-Down
HIMS
$16.69
-3.2%
-$0.55
Arrow-Thin-Down
DDOG
$127.33
-1.8%
-$2.34
Arrow-Thin-Down
SCHW
$95.53
-3.7%
-$3.72
Arrow-Thin-Down
CRDO
$128.40
-4.7%
-$6.32
Arrow-Thin-Down
AMZN
$204.25
-1.3%
-$2.71
Arrow-Thin-Down
GOOG
$311.32
-2.3%
-$7.31
Arrow-Thin-Down
META
$668.69
-0.3%
-$2.03
Arrow-Thin-Down
MSFT
$404.37
-2.2%
-$8.90
Arrow-Thin-Down
NVDA
$190.17
+0.9%
+$1.63
Arrow-Thin-Down
TSLA
$428.28
+0.7%
+$3.07
Most Active StocksDaily Stock GainersDaily Stock Losers
Abrdn Life Sciences Investors Stock Quote

Abrdn Life Sciences Investors (NYSE: HQL)

$16.95
(0.2%)
+0.03
Price as of February 11, 2026, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$16.95
Daily Change
(0.2%) +$0.03
Day's Range
$16.80 - $17.06
Previous Close
$16.95
Open
$17.06
Beta
0.75
Volume
130,899
Average Volume
134,882
Sector
Financials
Market Cap
$489M
Market Cap / Employee
$16.95M
52wk Range
$10.55 - $17.80
Revenue
N/A
Gross Margin
0.90%
Dividend Yield
10.74%
EPS
-$0.39
CAPs Rating
N/A
Industry
Capital Markets

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Abrdn Life Sciences Investors Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
HQL+40.02%+30.75%+5.51%+1,833%
S&P+14.39%+76.41%+12.02%+1,583%

Abrdn Life Sciences Investors Company Info

A business trust registered as a diversified, closed-end management investment company.

News & Analysis

Featured Article

The Best ETF for 2007: H&Q Life Sciences Investors

A biotech with a dividend twist.

Jim Fink  |  Nov 16, 2006
No financial data available at this time.

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services